These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22886530)
1. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530 [TBL] [Abstract][Full Text] [Related]
2. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma. Wang M; Deng X; Ying Q; Jin T; Li M; Liang C Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051 [TBL] [Abstract][Full Text] [Related]
4. MiR-34a-3p alters proliferation and apoptosis of meningioma cells Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma. Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122 [TBL] [Abstract][Full Text] [Related]
7. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408 [TBL] [Abstract][Full Text] [Related]
8. A microRNA expression signature predicts meningioma recurrence. Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195 [TBL] [Abstract][Full Text] [Related]
9. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969 [TBL] [Abstract][Full Text] [Related]
10. Functional significance of S6K overexpression in meningioma progression. Surace EI; Lusis E; Haipek CA; Gutmann DH Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284 [TBL] [Abstract][Full Text] [Related]
11. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
12. SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. Zhang Y; Yu R; Li Q; Li Y; Xuan T; Cao S; Zheng J J Cell Biochem; 2020 Feb; 121(2):1880-1889. PubMed ID: 31692066 [TBL] [Abstract][Full Text] [Related]
13. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064 [TBL] [Abstract][Full Text] [Related]
15. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526 [TBL] [Abstract][Full Text] [Related]
18. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
19. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307 [TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Liu ZY; Wang JY; Liu HH; Ma XM; Wang CL; Zhang XP; Tao YQ; Lu YC; Liao JC; Hu GH Oncogene; 2013 Mar; 32(10):1216-22. PubMed ID: 22614009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]